C260-2935 Screening compound: 2-[4-(1-{[(3-fluorophenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-(2-phenylethyl)acetamide

C260-2935 Screening compound: 2-[4-(1-{[(3-fluorophenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-(2-phenylethyl)acetamide
C260-2935 Screening compound: 2-[4-(1-{[(3-fluorophenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-(2-phenylethyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-2935
2-[4-(1-{[(3-fluorophenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-(2-phenylethyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-2935

Molecular Formula

C32H27FN4O4 (C32 H27 FN4 O4)

Compound Name

2-[4-(1-{[(3-fluorophenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-(2-phenylethyl)acetamide

IUPAC name

2-[4-(1-{[(3-fluorophenyl)carbamoyl]methyl}-24-dioxo-1234-tetrahydroquinazolin-3-yl)phenyl]-N-(2-phenylethyl)acetamide

SMILES

O=C(Cc(cc1)ccc1N(C(c(cccc1)c1N1CC(Nc2cccc(F)c2)=O)=O)C1=O)NCCc1ccccc1

InChI

InChI=1S/C32H27FN4O4/c33-24-9-6-10-25(20-24)35-30(39)21-36-28-12-5-4-11-27(28)31(40)37(32(36)41)26-15-13-23(14-16-26)19-29(38)34-18-17-22-7-2-1-3-8-22/h1-16,20H,17-19,21H2,(H,34,38)(H,35,39)

InChI Key

QDOFBIVUZALBBI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14739005

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

550.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.212

Distribution Coefficient, logD

3.212

Water Solubility, LogSw

-3.65

Polar Surface Area

77.846

Acid Dissociation Constant (pKa)

11.06

Base Dissociation Constant (pKb)

1.80

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

C260-2935 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C260-2935 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-2935?
Check Price and Availability of C260-2935, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-2935 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-2935
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-2935
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-2935 available by request